Farallon Capital Management
http://www.faralloncapital.com/farallon/index.htmFarallon Capital Management is an investment firm than manages equity capital for institutions and high net worth individuals. The firm's institutional investors are primarily college endowments and foundations. Farallon primarily invests in businesses and securities that are undergoing change or will appreciate because of an expected event which includes mergers, restructurings, recapitalizations or other major changes. The firm seeks to build strong relationships with the management of companies in which it invests.
View Older Stories View More Recent Stories
-
Playa Hotels & Resorts (PLYA) Prices 8.35M Share Secondary Offering at $8.35/sh
-
Playa Hotels & Resorts N.V. Announces Pricing of Secondary Offering of 8,352,553 Ordinary Shares by Selling Shareholders
-
Playa Hotels & Resorts (PLYA) Announces 8.35M Share Secondary Offering
-
Playa Hotels & Resorts N.V. Announces Secondary Offering of 8,352,553 Ordinary Shares by Selling Shareholders
-
Form SC 13G Better Therapeutics, Filed by: Farallon Capital Partners, L.P.
-
Cognex Corp (CGNX) Appoints Marjorie T. Sennett to its Board
-
Cognex Appoints New Board Member
-
Farallon Capital Opposes Terms Of Merck’s (MRK) Acceleron (XLRN) Takeover - Bloomberg
-
CP Group Secures Long-term Lease Agreement Months After Purchasing One Overton Park
-
Better Therapeutics Closes Business Combination and Debuts on Nasdaq
-
DNA Script Raises $165M in Oversubscribed Series C Financing to Accelerate Commercialization of Enzymatic DNA Printing Platform
-
Form SC 13G Marblegate Acquisition Filed by: Farallon Capital Partners, L.P.
-
Form SC 13G Berenson Acquisition Filed by: Farallon Capital Partners, L.P.
-
Form SC 13G Inflection Point Acquisi Filed by: Farallon Capital Partners, L.P.
-
Activist investor Elliott owns "significant" stake in Toshiba as review conducted
-
Ventyx Biosciences Announces Key Appointments and Closing of $51.0 Million Series B Convertible Preferred Stock Financing Round
-
InBrace Raises $102M Series D Financing
-
SomaLogic Closes Business Combination and Will Begin Trading Under the Ticker “SLGC” on the Nasdaq Stock Exchange
-
SomaLogic Closes Business Combination and Will Begin Trading Under the Ticker “SLGC” on the Nasdaq Stock Exchange
-
Zepz, Formerly WorldRemit Group, the Leading Digital Cross-border Payments Platform, Has Raised $292 Million in New Primary Series E Financing, Achieving a Valuation of $5 Billion
-
Form SC 13G Aramark Filed by: Farallon Capital Partners, L.P.
-
Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Mar 31
-
Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Dec 31
-
Form 13F-NT Farallon Capital Europe For: Jun 30
-
Form 13F-HR FARALLON CAPITAL MANAGEM For: Jun 30
-
Tango Therapeutics Debuts as Publicly Traded Precision Oncology Company Focused on the Next Generation of Targeted Cancer Therapies
-
Form SC 13G Mercury Ecommerce Acquis Filed by: Farallon Capital Partners, L.P.
-
Cell and Gene Therapy Firms Grab Over $11 Billion So Far in 2021
-
Form SC 13G Caribou Biosciences, Filed by: Farallon Capital Partners, L.P.
-
Zentera Therapeutics Announces Closing of $75 Million Series B Financing
-
Zentera Therapeutics Announces Closing of $75 Million Series B Financing
-
Form SC 13G Imago BioSciences, Inc. Filed by: Farallon Capital Partners, L.P.
-
Form D/A Farallon Capital F5 Inve
-
Form D/A Farallon Capital F5 Inve
-
Form SC 13G Shelter Acquisition Corp Filed by: Farallon Capital Partners, L.P.
-
POINT Biopharma Debuts as Publicly Traded Next-Generation Radiotherapeutics Company
-
POINT Biopharma Debuts as Publicly Traded Next-Generation Radiotherapeutics Company
-
Senior Japanese lawmaker accuses Toshiba activists of short-termism
-
Imago BioSciences’ Bomedemstat Demonstrates Continued Encouraging Clinical Activity in Phase 2 Data for Treatment of Essential Thrombocythemia and Myelofibrosis at EHA 2021 Virtual Congress
-
Imago BioSciences Appoints Wan-Jen Hong, M.D., as Chief Medical Officer
-
CP Group, Formerly Crocker Partners, Purchases Trio Of Prominent Atlanta Suburb Office Towers In Joint Venture With Farallon Capital Management
-
GenapSys Announces $70 Million in Series D Equity Financing and Expansion of its Board of Directors
-
Form SC 13D/A Playa Hotels & Resorts Filed by: FARALLON CAPITAL MANAGEMENT LLC
-
Imago BioSciences to Present Updated Data from Phase 2 Studies of Bomedemstat for the Treatment of Essential Thrombocythemia and Myelofibrosis at 2021 European Hematology Association Virtual Congress
-
BioTheryX Announces $92M Series E Financing to Accelerate Development of Targeted Protein Degradation Pipeline and Technology Platform in Oncology
-
Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Dec 31
-
Form 13F-NT Farallon Capital Europe For: Mar 31
-
Form 13F-HR FARALLON CAPITAL MANAGEM For: Mar 31
-
Toshiba unit hacked by DarkSide, conglomerate to undergo strategic review
-
Form SC 13G ARYA Sciences Acquisitio Filed by: Farallon Capital Partners, L.P.

